Intra Cellular Therapies shares owned by Silverarc Capital Management
Quarter-by-quarter ownership of Intra Cellular Therapies (ITCI) shares owned by Silverarc Capital Management
from 13F filings
Historical chart of Silverarc Capital Management investment in Intra Cellular Therapies
Tip: Access up to 7 years of quarterly data
All positions including Intra Cellular Therapies held by Silverarc Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Intra Cellular Therapies by Silverarc Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-09-30 | $11M | 209k | 52.09 |
| 2023-06-30 | $13M | 199k | 63.32 |
| 2023-03-31 | $6.8M | 125k | 54.15 |
| 2022-12-31 | $7.4M | 140k | 52.92 |
| 2022-09-30 | $6.3M | 136k | 46.53 |
| 2022-06-30 | $18M | 314k | 57.08 |
| 2022-03-31 | $19M | 309k | 61.19 |
| 2021-12-31 | $10M | 195k | 52.34 |
| 2021-09-30 | $3.8M | 102k | 37.28 |
| 2021-06-30 | $4.6M | 113k | 40.82 |
| 2021-03-31 | $4.4M | 130k | 33.93 |
| 2020-12-31 | $6.4M | 200k | 31.80 |
More positions owned by Silverarc Capital Management
View all positions for Silverarc Capital Management